News

BAB, Inc. Embraces Change and Reports Q2 2025 Results

BAB, Inc. Embraces Change and Reports Q2 2025 Results

BAB, Inc. Unveils Second Quarter Results for Fiscal 2025

In Deerfield, Ill., BAB, Inc. (OTCQB: BABB) has shared its financial outcomes for the second quarter, concluding on May 31, 2025. This announcement marks a significant moment for the company as they navigate the evolving business landscape.

Revenue Insights

For the quarter ending May 31, 2025, BAB generated revenues of $808,000 alongside a net income of $154,000, equating to earnings of $0.02 per share. Compared to the same quarter last year, when revenues stood at $883,000 and net income was $146,000 for identical earnings per share, it’s clear that the company has experienced a decrease in revenue. Notably, this decline is primarily driven by reduced marketing fund expenses, which also affect the recognition of associated revenues. It's important to understand that under U.S. GAAP, these revenues are acknowledged concurrently with the incurred expenses, thereby offsetting any direct impact on net income.

Half-Year Performance

When considering the six months through May 31, 2025, BAB, Inc. reported revenues of $1,566,000 and net income reaching $271,000, or $0.04 per share. That is down from the 2024 period, which recorded $1,719,000 in revenues and net earnings of $244,000 or $0.03 per share. The primary driver of the revenue drop is linked again to decreases in marketing fund expenses, mirroring trends seen over the previous quarter.

Analysis of Operating Expenses

For the three-month period ending May 31, 2025, total operating expenses were reported at $608,000. This reflects a decline from $696,000 registered during the same quarter in 2024. Several factors contributed to this change, including reductions in marketing fund expenses by $80,000, a decrease in professional services by $15,000, and cuts to employee benefits by $14,000, along with a $6,000 lower occupancy expense. However, a $7,000 increase in payroll expenses and a $20,000 rise in other expenses moderated this decline.

Looking at Trends

When analyzing expenses for the six months ending May 31, total operational costs were $1,218,000 compared to $1,410,000 in the prior year. Notably, the marketing department has plans to increase expenditures in the forthcoming third and fourth quarters of fiscal 2025, aiming to complete various scheduled projects.

Franchise and Licensing Overview

BAB, Inc. continues to thrive as it franchises and licenses well-known brands, including Big Apple Bagels®, My Favorite Muffin®, SweetDuet® frozen yogurt, and Brewster’s® Coffee. The company places immense value on its brand’s visibility and market presence, leveraging its established portfolio to tap into new growth opportunities.

Contact Information

For additional information, stakeholders can reach out to BAB, Inc. at:

Michael K. Murtaugh
(847) 948-7520
Fax: (847) 405-8140
www.babcorp.com

Frequently Asked Questions

What were BAB, Inc.'s total revenues for Q2 2025?

The company reported total revenues of $808,000 for the second quarter of fiscal 2025.

How much did the net income amount to?

The net income for the second quarter was $154,000, translating to earnings of $0.02 per share.

Why did revenue decrease compared to last year?

The decline in revenue was primarily due to decreased marketing fund expenses, which also influence the recognition of marketing fund revenue.

What are BAB, Inc.'s future spending plans?

The marketing department plans to increase spending in upcoming quarters to support scheduled marketing projects.

Which brands does BAB, Inc. franchise?

BAB, Inc. franchises well-known brands such as Big Apple Bagels®, My Favorite Muffin®, SweetDuet® frozen yogurt, and Brewster’s® Coffee.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Madrigal Faces Legal Scrutiny Amid Whistleblower Claims

Updated Category News Views 233

The Storm Brewing Over Madrigal Pharmaceuticals Well, folks, here we are smack dab in the middle of another roller-coaster ride in the biotech sector, and it ain't pretty. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is in hot water with some serious allegations thrown their way. The company is now under investigation by Kessler Topaz Meltzer & Check, LLP, a top-notch...

Continue Reading
Key Players Depart No Makeup Makeup Amid Rapid Success

Updated Category News Views 214

Change is afoot in the world of beauty. No Makeup Makeup, a brand that's managed to carve out a sizable niche, recently bid farewell to two of its main architects: Kim Wileman and Shauna Lahiri. These women didn't just steer the ship; they built the damn thing. Kicking Off the No Makeup Revolution Wileman and Lahiri were the pistons firing away at No Makeup Makeup, a...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 212

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Koppers Faces Investigation: Investors Cautious Amid Probe

Updated Category News Views 211

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

Continue Reading
DraftKings Faces Revenue Cutback; Legal Probe Begins

Updated Category News Views 190

DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...

Continue Reading
Blue Owl Tech Faces Lawsuit Post-44% Share Dive

Updated Category News Views 59

The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....

Continue Reading
Tenax Therapeutics Faces Legal Heat After Stock Plunge

Updated Category News Views 133

Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 151

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 82

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 206

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading

Top 5 Most Recently Viewed Articles

UGO Token Revolutionizes Trading with Innovative Launch

Updated Category News Views 216

UGO Token Launching on PancakeSwap UGO, the latest addition to the innovative ecosystem featuring Gooo and WeGo, is set to make waves in the trading sphere with its exceptional Hybrid Token Model. This new framework emphasizes fairness, sustainability, and real-world utility, offering an exciting opportunity for both everyday traders and crypto enthusiasts alike. What...

Continue Reading
Empyrean Anaheim Faces Legal Battle Over Wage Practices

Updated Category News Views 33

California Labor Law Clashes in the Spotlight When a lawsuit against a big name like Empyrean Anaheim Resort hits headlines, it raises eyebrows. Folks, we're talking about a class action filed in California, no less—a state with some of the toughest labor laws around. The legal eagles at Blumenthal Nordrehaug Bhowmik De Blouw LLP are on the case, claiming Empyrean...

Continue Reading
China's Diplomatic Efforts to Stabilize Middle East Oil Market

Updated Category News Views 174

China's Role in Mediating Middle Eastern Conflicts As the world’s second-largest oil consumer, China is stepping into a critical role by urging Israel and Iran to de-escalate their ongoing tensions. In this complex geopolitical landscape, China's top diplomat, Wang Yi, took proactive measures through separate phone calls with officials from both nations, advocating for...

Continue Reading
Jason Wyatt: Transforming Leadership and Achieving Success

Updated Category News Views 524

Jason Wyatt Recognized for His Exceptional Leadership In a remarkable acknowledgment by The Inner Circle, Jason Wyatt, an esteemed CEO, is honored as an Inner Circle Lifetime member. This recognition is a testament to his significant contributions to Transforming Leadership and Driving Success Through Innovative Coaching. Jason Wyatt's Innovative Approach to Leadership As...

Continue Reading
Terray Therapeutics Secures $120M Series B for Drug Innovation

Updated Category News Views 293

Terray Therapeutics Secures Significant Series B Investment Terray Therapeutics, a dynamic player in the biotechnology sector, has successfully closed an oversubscribed Series B funding round, raising $120 million. This investment aims to advance the company's unique generative AI pipeline for small molecule therapeutics, enhancing their capabilities to bring innovative...

Continue Reading